Desmoplastic Small Round Cell Tumor (DSRCT) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Conditions: Leiomyosarcoma; Liposarcoma; Synovial Sarcoma; Angiosarcoma; Undifferentiated Pleomorphic Sarcoma; Epithelioid Sarcoma; Malignant Peripheral Nerve Sheath Tumors; Fibrosarcoma; Pleomorphic Rhabdomyosarcoma; Endometrial Stromal Sarcoma; Desmoplastic Small Round Cell Tumor Interventions: Biological: MASCT-I; Drug: Doxorubicin; Drug: Ifosfamide Sponsors: HRYZ Biotech Co. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
Condition: Desmoplastic Small Round Cell Tumor Intervention: Sponsor: Memorial Sloan Kettering Cancer Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2020 Category: Research Source Type: clinical trials
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
Condition: Desmoplastic Small Round Cell Tumor Intervention: Sponsor: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2020 Category: Research Source Type: clinical trials
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
Condition: Desmoplastic Small Round Cell Tumor Intervention: Sponsor: Memorial Sloan Kettering Cancer Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2020 Category: Research Source Type: clinical trials
CAMFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Condition: Desmoplastic Small Round Cell Tumor Interventions: Drug: Ramucirumab; Drug: Cyclophosphamide; Drug: Vinorelbine Sponsor: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2019 Category: Research Source Type: clinical trials